These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 8392995

  • 1. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors.
    Thomson CJ, Amyes SG.
    J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995
    [Abstract] [Full Text] [Related]

  • 2. Back mutations to the TEM-1 beta-lactamase from TRC-1 lead to restored sensitivity to clavulanic acid.
    Thomson CJ, Amyes SG.
    J Med Microbiol; 1995 Jun; 42(6):429-32. PubMed ID: 7791208
    [Abstract] [Full Text] [Related]

  • 3. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli.
    Blazquez J, Baquero MR, Canton R, Alos I, Baquero F.
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2059-63. PubMed ID: 8257123
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative in vitro activities of amoxicillin-clavulanate, ampicillin-sulbactam and piperacillin-tazobactam against strains of Escherichia coli and proteus mirabilis harbouring known beta-lactamases.
    Gatermann S, Marre R.
    Infection; 1991 Oct; 19(2):106-9. PubMed ID: 1646771
    [Abstract] [Full Text] [Related]

  • 6. OHIO-1 beta-lactamase resistant to mechanism-based inactivators.
    Bonomo RA, Currie-McCumber C, Shlaes DM.
    FEMS Microbiol Lett; 1992 Apr 01; 71(1):79-82. PubMed ID: 1320587
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .
    Livermore DM, Seetulsingh P.
    J Antimicrob Chemother; 1991 Jun 01; 27(6):761-7. PubMed ID: 1669013
    [Abstract] [Full Text] [Related]

  • 13. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M, Moittie D, Philippon A, Descamps P, Veron M.
    J Antimicrob Chemother; 1989 May 01; 23(5):798-800. PubMed ID: 2547748
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.
    Muratani T, Yokota E, Nakane T, Inoue E, Mitsuhashi S.
    J Antimicrob Chemother; 1993 Sep 01; 32(3):421-9. PubMed ID: 8262864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasmid encoded beta-lactamases resistant to inhibition by clavulanic acid produced by calf faecal coliforms.
    Hunter JE, Corkill JE, McLennan AG, Fletcher JN, Hart CA.
    Res Vet Sci; 1993 Nov 01; 55(3):367-70. PubMed ID: 8284502
    [Abstract] [Full Text] [Related]

  • 18. Characterization of a beta-lactamase produced by Pseudomonas paucimobilis.
    Corkill JE, Hart CA, McLennan AG, Aspinall S.
    J Gen Microbiol; 1991 Jun 01; 137(6):1425-9. PubMed ID: 1655952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.